United States of America – The Insight Partners today announced the release of a comprehensive new Cell and Gene Therapy Contract Development and Manufacturing Organization Market report, projecting significant expansion through 2031. This extensive study reveals how personalized medicine, artificial intelligence-driven manufacturing, and strategic global partnerships are redefining...

In the age of precision medicine and biotech breakthroughs, one sector is quietly powering some of the most transformative therapies in healthcare — Cell and Gene Therapy CDMOs (Contract Development and Manufacturing Organizations). These specialized players are the behind-the-scenes engines that help bring revolutionary treatments from the lab to the bedside. With personalized medicine...